Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study on prevention of hypercapnia by nasal high flow in patients undergoing endoscopic retrograde cholangiopancreatography during intravenous anesthesia.
Ayuse T, Sawase H, Ozawa E, Nagata K, Komatsu N, Sanuki T, Kurata S, Mishima G, Hosogaya N, Nakashima S, Pinkham M, Tatkov S, Kazuhiko N. Ayuse T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 May;99(19):e20036. doi: 10.1097/MD.0000000000020036. Medicine (Baltimore). 2020. PMID: 32384464 Free PMC article.
Examination of pain relief effect of Goreisan for glossodynia.
Ayuse T, Okayasu I, Tachi-Yoshida M, Sato J, Saisu H, Shimada M, Yamazaki Y, Imura H, Hosogaya N, Nakashima S. Ayuse T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Aug 14;99(33):e21536. doi: 10.1097/MD.0000000000021536. Medicine (Baltimore). 2020. PMID: 32872000 Free PMC article.
An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.
Koga T, Hagimori N, Sato S, Morimoto S, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Jan;99(1):e18328. doi: 10.1097/MD.0000000000018328. Medicine (Baltimore). 2020. PMID: 31895769 Free PMC article.
Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Shimizu T, Kawashiri SY, Sato S, Morimoto S, Minoda S, Kawazoe Y, Kuroda S, Tashiro S, Sumiyoshi R, Hosogaya N, Yamamoto H, Kawakami A. Shimizu T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Aug 7;99(32):e21480. doi: 10.1097/MD.0000000000021480. Medicine (Baltimore). 2020. PMID: 32769882 Free PMC article.
Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant).
Sumiyoshi R, Koga T, Shimizu T, Sato S, Tashiro S, Hosogaya N, Yamamoto H, Kawakami A. Sumiyoshi R, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Dec 11;99(50):e22708. doi: 10.1097/MD.0000000000022708. Medicine (Baltimore). 2020. PMID: 33327226 Free PMC article. Clinical Trial.
An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant).
Koga T, Takemori S, Hagimori N, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Dec 11;99(50):e23291. doi: 10.1097/MD.0000000000023291. Medicine (Baltimore). 2020. PMID: 33327255 Free PMC article.
Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial.
Koga T, Hagimori N, Takemori S, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Jul 24;99(30):e20710. doi: 10.1097/MD.0000000000020710. Medicine (Baltimore). 2020. PMID: 32791665 Free PMC article.
Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound, and biomarker assessments.
Kawashiri SY, Shimizu T, Sato S, Morimoto S, Kawazoe Y, Sumiyoshi R, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Kawashiri SY, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Jul 24;99(30):e21151. doi: 10.1097/MD.0000000000021151. Medicine (Baltimore). 2020. PMID: 32791688 Free PMC article.
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S; Nelfinavir Study Group. Hosogaya N, et al. Trials. 2021 Apr 28;22(1):309. doi: 10.1186/s13063-021-05282-w. Trials. 2021. PMID: 33910617 Free PMC article.
45 results